Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib. [electronic resource]
Producer: 20100624Description: e200-1 p. digitalISSN:- 1873-5835
- Antineoplastic Agents -- adverse effects
- Benzamides
- Drug Resistance, Neoplasm
- Humans
- Hypereosinophilic Syndrome -- drug therapy
- Imatinib Mesylate
- Male
- Middle Aged
- Piperazines -- adverse effects
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- adverse effects
- Salvage Therapy
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.